Respiratory Syncytial Virus Diagnostics Market Size, Outlook, Future Analysis And Synthesis By 2026 Respiratory Syncytial Virus (RSV) is responsible for many chronic conditions such as pneumonia, bronchitis, asthma, and respiratory disease. It primarily affects neonates, infants and adults and is responsible for outpatient visits, hospitalization and death in some cases. Therefore, diagnosis of RSVassociated diseases is crucial to avoid further medical severity. Symptoms of RSV presence include, rhinorrhea, cough, wheeze, respiratory distress, and hypoxemia. Molecular diagnostic is most widely used techniques for diagnosing RSV. Respiratory Syncytial Virus Diagnostics Market - Market Dynamics High prevalence of respiratory infections due to RSV is a major factor driving growth of the respiratory syncytial virus diagnostics market. According to a report by the Lancet, 2017, around 33·1 million episodes of RSV induced acute lower respiratory infections that resulted in around 3·2 million hospitalizations and around 59,600 in-hospital deaths in children younger than 5 years of age, worldwide, in 2015. Moreover, the report stated that the overall RSV- acute lower respiratory infectionsrelated mortality was around 118200 in 2015. Ask for In-depth Sample Copy of This Research at https://www.coherentmarketinsights.com/insight/request-sample/2038 Furthermore, high prevalence of several chronic conditions such as pneumonia and other respiratory tract infections due to RSV is a major factor contributing to growth of the market over the forecast period. For instance, according to a report by World Health Organization (WHO), May 2018, chronic obstructive pulmonary disease (COPD) and lower respiratory tract infection are amongst top five chronic diseases with highest mortality rate, worldwide. The report stated that around 3 million each deaths were registered due to COPD and lower respiratory tract infection in 2016, worldwide. Report includes chapters which deeply display the following deliverable about industry : • Respiratory Syncytial Virus Diagnostics Market Research Objective and Assumption • Respiratory Syncytial Virus Diagnostics Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Respiratory Syncytial Virus Diagnostics Market Dynamics, Regulations, and Trends Analysis Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Respiratory Syncytial Virus Diagnostics Market, By Regions • Respiratory Syncytial Virus Diagnostics Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Respiratory Syncytial Virus Diagnostics Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Respiratory Syncytial Virus Diagnostics Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Respiratory Syncytial Virus Diagnostics Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Respiratory Syncytial Virus Diagnostics Market - Regional Insights On the basis of Geography, respiratory syncytial virus diagnostics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be dominant in the respiratory syncytial virus diagnostics market over the forecast period. According to study published in journal American Family Physician in 2017, around 2% to 3% of infants, younger than 12 months are hospitalized with an RSV infection, annually, in the U.S. As per same source, Around 57,500 hospitalizations and 2.1 million outpatient visits are associated with RSV infections in children younger than five years, annually, in the U.S. It can be concluded from epidemiological data that the U.S. has high potential for respiratory syncytial virus diagnostics market. Presence of key players and their products in North America would be another important driver for the market growth. Respiratory Syncytial Virus Diagnostics Market - Competitive Landscape Key players operating in the respiratory syncytial virus diagnostics market include, F. Hoffmann LaRoche AG , Becton, Dickinson and Company, Novartis AG, Abbott Laboratories, Ortho Clinical Diagnostics, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., BioMerieux, DiaSorin SPA, Millipore-sigma, Quidel Corporation, Alere Inc., Coris BioConcept, Fast-track Diagnostics, and Quest Diagnostics. Respiratory Syncytial Virus Diagnostics Market - Market Taxonomy - On the basis of diagnostic techniques: Molecular Diagnostics, Direct Fluorescent Antibody (DFA) Method, Rapid Antigen Diagnostic Test, Monoclonal Antibodies, Flow Cytometry, Diagnostic Imaging, Immnunochromgraphic Assay, Gel Microdroplets, Others - On the basis of end user: Hospitals, Diagnostic Centers, Commercial Radioisotope Manufacturers - On the basis of region: North America, Latin America, Europe, Asia Pacific, Middle East, Africa Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2038 About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]
High prevalence of respiratory infections due to RSV is a major factor driving growth of the respiratory syncytial virus diagnostics market.
© Copyright 2024 Paperzz
